Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 26% ± 8% | |
T cell | 5 studies | 22% ± 4% | |
CD4-positive, alpha-beta T cell | 5 studies | 28% ± 7% | |
hematopoietic precursor cell | 4 studies | 20% ± 3% | |
CD8-positive, alpha-beta T cell | 4 studies | 27% ± 2% | |
plasmablast | 3 studies | 36% ± 16% | |
basal cell | 3 studies | 20% ± 3% | |
pro-B cell | 3 studies | 29% ± 5% | |
GABAergic neuron | 3 studies | 24% ± 4% | |
glutamatergic neuron | 3 studies | 30% ± 6% | |
erythrocyte | 3 studies | 32% ± 17% | |
transit amplifying cell | 3 studies | 43% ± 13% | |
natural killer cell | 3 studies | 28% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 1867.77 | 359 / 359 | 100% | 58.76 | 286 / 286 |
esophagus | 100% | 2667.23 | 1444 / 1445 | 100% | 77.11 | 183 / 183 |
breast | 100% | 2125.85 | 459 / 459 | 100% | 83.68 | 1116 / 1118 |
uterus | 100% | 1888.37 | 170 / 170 | 100% | 95.28 | 457 / 459 |
lung | 99% | 1810.54 | 574 / 578 | 100% | 63.63 | 1155 / 1155 |
intestine | 100% | 2157.52 | 966 / 966 | 99% | 62.26 | 523 / 527 |
prostate | 100% | 1738.67 | 245 / 245 | 99% | 43.42 | 497 / 502 |
bladder | 100% | 2142.33 | 21 / 21 | 98% | 61.91 | 494 / 504 |
brain | 97% | 1290.41 | 2570 / 2642 | 99% | 47.21 | 701 / 705 |
skin | 100% | 5591.14 | 1809 / 1809 | 97% | 53.20 | 456 / 472 |
thymus | 100% | 1416.42 | 652 / 653 | 97% | 42.31 | 585 / 605 |
ovary | 100% | 1869.03 | 180 / 180 | 96% | 31.58 | 411 / 430 |
pancreas | 96% | 1084.87 | 316 / 328 | 99% | 37.49 | 176 / 178 |
kidney | 97% | 1087.31 | 86 / 89 | 91% | 29.12 | 818 / 901 |
adrenal gland | 100% | 3411.19 | 258 / 258 | 82% | 26.23 | 189 / 230 |
liver | 80% | 697.56 | 180 / 226 | 85% | 26.87 | 346 / 406 |
adipose | 100% | 2040.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 82.57 | 29 / 29 |
muscle | 100% | 2559.07 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1622.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 125.03 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.19 | 1 / 1 |
blood vessel | 100% | 2383.08 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 90% | 1270.93 | 776 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 19.40 | 62 / 80 |
peripheral blood | 57% | 2662.40 | 533 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006281 | Biological process | DNA repair |
GO_0010971 | Biological process | positive regulation of G2/M transition of mitotic cell cycle |
GO_0021846 | Biological process | cell proliferation in forebrain |
GO_0006264 | Biological process | mitochondrial DNA replication |
GO_0010212 | Biological process | response to ionizing radiation |
GO_0070318 | Biological process | positive regulation of G0 to G1 transition |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0009263 | Biological process | deoxyribonucleotide biosynthetic process |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0009185 | Biological process | ribonucleoside diphosphate metabolic process |
GO_0009265 | Biological process | 2'-deoxyribonucleotide biosynthetic process |
GO_0051290 | Biological process | protein heterotetramerization |
GO_0000731 | Biological process | DNA synthesis involved in DNA repair |
GO_0008584 | Biological process | male gonad development |
GO_0006206 | Biological process | pyrimidine nucleobase metabolic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005829 | Cellular component | cytosol |
GO_0042995 | Cellular component | cell projection |
GO_0005971 | Cellular component | ribonucleoside-diphosphate reductase complex |
GO_0061731 | Molecular function | ribonucleoside-diphosphate reductase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004748 | Molecular function | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor |
GO_0097718 | Molecular function | disordered domain specific binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RRM1 |
Protein name | Ribonucleoside-diphosphate reductase (EC 1.17.4.1) Ribonucleotide reductase catalytic subunit M1 Ribonucleoside-diphosphate reductase large subunit (Ribonucleotide reductase large subunit) Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) |
Synonyms | RR1 |
Description | FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. . |
Accessions | E9PP77 E9PRY9 ENST00000300738.10 E9PL69 E9PJ62 H0YCY7 ENST00000533349.5 ENST00000528442.5 P23921 ENST00000533495.5 ENST00000532170.5 ENST00000534285.5 |